Orchidia Pharmaceutical Industries obtained the approval of Sudan Ministry of Health to register five of the company's eye drops, as the company obtained the pricing certificates of the 5 products in accordance with the regulations adopted in Sudan.
The five Eye Drops are:
Conjyclear (Olopatadine Hydrochloride 1.11 mg), Anti-Allergic Eye Drop.
Orchazid (Ketotifen Fumarate 0.345 mg), Anti-Allergic Eye Drop.
Ozolmide (Dorzolamide Hydrochloride 20 mg), Anti-Glaucoma Eye Drop.
Twinzol (Dorzolamide Hydrochloride 22.26 mg), Anti-Glaucoma Eye Drop.
Gatistar (Gatifloxacin 5 mg), Antibiotic Eye Drop.
It should be noted that the company has registered in Sudan three products classified as Medical Devices, and these are:
Perfect Care, Contact-Lens Solution.
Tears Guard, Artificial Tears, and Eye Lubricant.
Poly-fresh, Artificial Tears, and Eye Lubricant.
The company plans to introduce the eight products in the Sudanese market by the beginning of 2018.
